Guillermo Iglesias


Guillermo Iglesias-Salto has been a lecturer and researcher in the Department of Applied Physics at the University of Granada since 2005.  He specialises in magnetic fluids and magnetic hyperthermia application, the physical properties of solid/liquid interface, Biomimetic Magnetic Nanoparticles, nanoparticle-based drug delivery. He is author of more than 65 journal publications (h-index 18; i10 index 35) with about 1300 citations in the last 7 years, and more than 50 conference presentations.  He has been principal investigator of 4 national and regional research projects, and co-author of 13 patents, managing more than 600K€ research budget. He has a strong experience supervising PhD researchers enhancing their research career which are multidisciplinary in nature. He also worked as executive in technological companies as Teléfonica and Ericsson for six years. In early 2012, he has led the area of magnetic hyperthermia and photothermia to date.

The efforts of his main research area have been mainly devoted to the synthesis of nanoparticles with controllable size, shape and surface functionalities. Specifically, within the framework of project RyC-2014-16901, entitled "New technologies based on nanoparticle systems", the group's interest has focused mainly on the design and evaluation of nanoparticle-based drug delivery vehicles, in which the inclusion of one or several magnetic cores allows controlling the location of the particle, as well as its approach to a given target.

The most relevant publications of the last 2 years have been:

1 Enhanced Cytotoxic Effect of TAT–PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia Pharmaceutics. 2021-07-28. DOI: 10.3390/pharmaceutics13081168

2 Poly(ethylene-imine)-Functionalized Magnetite Nanoparticles Derivatized with Folic Acid: Heating and Targeting Properties. Polymers. 2021-05-15. DOI: 10.3390/polym13101599

3 Synergistic Photothermal-Chemotherapy Based on the Use of Biomimetic Magnetic Nanoparticles. Pharmaceutics. 2021-04-28. DOI: 10.3390/pharmaceutics13050625

4 Improving the Cellular Uptake of Biomimetic Magnetic Nanoparticles. Nanomaterials. 2021-03-18. DOI: 10.3390/nano11030766

5 Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies. Nanomaterials. 2021-03-03. DOI: 10.3390/nano11030627

6 Biomimetic Magnetite Nanoparticles as Targeted Drug Nanocarriers and Mediators of Hyperthermia in an Experimental Cancer Model. Cancers. 2020-09-09. DOI: 10.3390/cancers12092564

7 Nanoformulation Design Including MamC-Mediated Biomimetic Nanoparticles Allows the Simultaneous Application of Targeted Drug Delivery and Magnetic Hyperthermia. Polymers. 2020-08-15. DOI: 10.3390/polym12081832

8 Reactive oxygen species (ROS) production in HepG2 cancer cell line through the application of localized alternating magnetic field. Journal of Materials Chemistry B. 2020. DOI: 10.1039/D0TB01306D